NCT02822768 Packing Versus no Packing for Cutaneous Abscess
| NCT ID | NCT02822768 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Cutaneous Abscess |
| Study Type | INTERVENTIONAL |
| Enrollment | 196 participants |
| Start Date | 2016-08 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 196 participants in total. It began in 2016-08 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to examine patients undergoing incision and drainage of cutaneous abscesses to determine if routine packing of the abscess cavity affects the need for further interventions such as repeat incision and drainage, antibiotic administration or hospital admission.
Eligibility Criteria
Inclusion Criteria: 1. All patients 18 years of age and above 2. Patients that require a cutaneous abscess incision and drainage 3. English-speaking subjects only Exclusion Criteria: 1. Unable to return for 48-hour follow-up. 2. Patients being admitted to the hospital or going to the operating room for incision and drainage 3. Pregnant patients 4. Patients less than 18 years of age 5. Prisoners or persons in police custody 6. Patients with infected bursa 7. Non-English speaking subjects
Contact & Investigator
Michael Darracq, MD, MPH
PRINCIPAL INVESTIGATOR
UCSF - Fresno
Frequently Asked Questions
Who can join the NCT02822768 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cutaneous Abscess. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02822768 currently recruiting?
Yes, NCT02822768 is actively recruiting participants. Contact the research team at mdarracq@fresno.ucsf.edu for enrollment information.
Where is the NCT02822768 trial being conducted?
This trial is being conducted at Fresno, United States.
Who is sponsoring the NCT02822768 clinical trial?
NCT02822768 is sponsored by University of California, San Francisco. The principal investigator is Michael Darracq, MD, MPH at UCSF - Fresno. The trial plans to enroll 196 participants.